With a new CRISPR gene-editing methodology, scientists from the University of Illinois at Urbana-Champaign inactivated one of the genes responsible for an inherited form of amyotrophic lateral sclerosis – a debilitating and fatal neurological disease for which there is no cure. The novel treatment slowed disease progression, improved muscle function and extended lifespan in mice with an aggressive form of ALS.
“ALS unfortunately has few treatment options. This is an important first step in showing that this new form of gene editing could be used to potentially treat the disease,” said bioengineering professor Thomas Gaj, who co-led the study with bioengineering professor Pablo Perez-Pinera.
The method relied on an emerging gene-editing technology known as CRISPR base editors.
Traditional CRISPR gene-editing technologies cut both strands of a DNA molecule, which can introduce a variety of errors in the DNA sequence, limiting its efficiency and potentially leading to a number of unintended mutations in the genome. The Illinois group instead used base editing “to change one letter of the DNA sequence to another without cutting through both DNA strands,” Perez-Pinera said.
“Base editors are too large to be delivered into cells with one of the most promising and successful gene therapy vectors, known as adeno-associated virus,” Gaj said. However, in 2019, Perez-Pinera’s group developed a method of splitting the base editor proteins into halves that can be delivered by two separate AAV particles. Once inside the cell, the halves reassemble into the full-length base editor protein.
By combining the power of AAV gene delivery and split-base editors, Gaj and Perez-Pinera targeted and permanently disabled a mutant SOD1 gene, which is responsible for roughly 20% of inherited forms of ALS. They published their results in the journal Molecular Therapy.
“Many ALS studies are focused on preventing or delaying the onset of the disease. However, in the real world, most patients are not diagnosed until symptoms are advanced,” said graduate student Colin Lim. “Slowing progression, rather than preventing it, may have a greater impact on patients.” Lim is the co-first author of the study along with graduate students Michael Gapinske and Alexandra Brooks.
The Latest Updates from Bing News & Google News
Go deeper with Bing News on:
Lou Gehrig’s disease
- 'Absolutely heartbreaking': David Niven's agonising health battle that led to his death
DAVID NIVEN's death in 1983 came as a shock to many in the arts and beyond. The British great faced a gruelling health battle that ultimately cost him his life. In a 2009 interview, Niven's son, David ...
- ALS Association’s Fiesta raises $208,000 to help people with Lou Gehrig Disease ...community news
The ALS Association in San Diego's Fiesta raises $208,000 ... peek at this week's North County events concerts, fairs, performances, art shows, community meetings ...
- Yankees icon Lou Gehrig once owned this colonial home in New York. Peer inside
The sellers “preserved the character of the architecture, and both restored and renovated everything,” the listing agent told Mansion Global.
- Yankee great Lou Gehrig's New Rochelle home back on the market
New York Yankees great Lou Gehrig was known for many things. He was a record-setting Hall of Fame first baseman and the first major league player to have his jersey, No. 4, retired. He's also widely ...
- Former New Rochelle Home of New York Yankees Great Lou Gehrig Lists for $1.5 Million
A four-bedroom home once owned by New York Yankees legendary first baseman Lou Gehrig came on the market last week asking $1.459 million. Located in New Rochelle, New York—just 14 miles north of ...
Go deeper with Google Headlines on:
Lou Gehrig’s disease
Go deeper with Bing News on:
- 'He was like a father figure': Buckeye, ALS communities remember William White
William White, former all-American defensive back, died after battling ALS, at 56 years old. White impacted not only the Buckeye community but inspired others who were suffering from ALS and helped ...
- Inside the CFL: Als centre Sean Jamieson relishes playing a kid's game
Sean Jamieson isn’t the first — and certainly won’t be the last — professional football player who has to practise and play with braces on both knees after undergoing three serious injuries, the first ...
- Artificial Intelligence & ALS: Identifying Drug Candidates for A Cure
A new study has found that utilizing AI and existing research could improve the potential for developing more effective drugs for a disease that offers few current treatment options.
- The Als aren’t good enough — and they haven't even hit rock bottom yet
The eternal optimist will suggest the Alouettes were able to play against the Winnipeg Blue Bombers — the best team in the CFL — at home for 41 minutes on Thursday night. But the realist will look at ...
- One Week Until CEO Soak Event to Benefit ALS: August 11th at 1pm in Clinton Square
The ALS Association Upstate New York Chapter and Advance Media NY will team up to raise critical funds and awareness for the fight against ALS by participating in The ALS Association’s CEO Soak on ...